by Jordana Choucair | Feb 7, 2022 | Payers
California has negotiated a deal that allows Kaiser Permanente to limit enrollment primarily to its previous enrollees, except in the case of foster kids and people who are eligible for both Medicare and Medi-Cal. Executives of other managed-care insurance plans in...
by Jordana Choucair | Feb 7, 2022 | Life Sciences
The FDA will restart its domestic pharma-related surveillance inspections today after pausing the program in December. The agency has been stopping and starting since the COVID-19 pandemic began to “ensure the safety of its employees and those of the firms it...
by Jordana Choucair | Feb 7, 2022 | D.C. News
Numerous influential physicians and public health advocacy groups are pushing senators to confirm Dr. Robert Califf, President Biden’s nominee for FDA Commissioner. The calls come amid concerns from both Democrats and Republicans and opposition from...
by Jordana Choucair | Feb 4, 2022 | Providers
The Biden administration announced the availability of $19.2 million in grants to train primary care residents in rural and under-served communities, part of an effort to address physician shortages. The Health Resources and Services Administration funding will...
by Jordana Choucair | Feb 4, 2022 | Payers
The Biden administration announced that Medicare will begin covering at-home COVID-19 tests in early spring for its 64 million beneficiaries. The CMS said people on Medicare will be able to get up to eight tests per month at select pharmacies and other locations, but...
by Jordana Choucair | Feb 4, 2022 | Life Sciences
Eli Lilly and Co. pushed back its timeline to ask regulators to grant accelerated approval to its experimental Alzheimer’s disease drug. The drugmakers said approval would have little impact on its business this year given Medicare officials’ decision to...
Recent Comments